Handels, H;Horsch, A;Meinzer, HP.Advances in medical image computing..Methods Inf Med.2007.46.3.251-3

Horsch, A;Khoshsima, D.Towards modeling and simulation of integrated social and health care services for elderly..Medinfo.2007.12.Pt 1.38-42

Linde, K;Witt, CM;Streng, A;Weidenhammer, W;Wagenpfeil, S;Brinkhaus, B;Willich, SN;Melchart, D.The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain..Pain.2007.128.3.264-71

Leucht, S;Davis, JM;Engel, RR;Kane, JM;Wagenpfeil, S.Defining'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs..Neuropsychopharmacology.2007.32.9.1903-10

Egert, S;Wagenpfeil, S;Förstl, H.[Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].Dtsch Med Wochenschr.2007.132.22.1207-13

Jarius, S;Eichhorn, P;Albert, MH;Wagenpfeil, S;Wick, M;Belohradsky, BH;Hohlfeld, R;Jenne, DE;Voltz, R.Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent way..Blood.2007.109.10.4376-82

Diehl-Schmid, J;Pohl, C;Ruprecht, C;Wagenpfeil, S;Foerstl, H;Kurz, A.The Ekman 60 Faces Test as a diagnostic instrument in frontotemporal dementia..Arch Clin Neuropsychol.2007.22.4.459-64

Lepper, PM;Schumann, C;Triantafilou, K;Rasche, FM;Schuster, T;Frank, H;Schneider, EM;Triantafilou, M;von Eynatten, M.Association of lipopolysaccharide-binding protein and coronary artery disease in men..J Am Coll Cardiol.2007.50.1.25-31

Gansera, B;Schmidtler, F;Angelis, I;Botzenhardt, F;Schuster, T;Kiask, T;Haschemi, A;Kemkes, BM.Quality of internal thoracic artery grafts after mediastinal irradiation..Ann Thorac Surg.2007.84.5.1479-84

Kümmel, S;Eggemann, H;Lüftner, D;Gebauer, N;Bühler, H;Schaller, G;Schmid, P;Kreienberg, R;Emons, G;Kriner, M;Elling, D;Blohmer, JU;Thomas, A.Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes..Int J Biol Markers.2007.22.3.186-93